12.60

2.86% 0.35

Nextcure Inc (NXTC)

Overview News Price History Option Chain Financials Why NXTC Down? Discussions Forecast

Nextcure Inc stock is traded at $12.60, with a volume of 38,884. It is up +2.86% in the last 24 hours and up +115.02% over the past month. NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.

Previous Close:

$12.25

Open:

$12.25

24h Volume:

38,884

Relative Volume:

1.04

Market Cap:

$33.72M

Revenue:

Net Income/Loss:

$-58.52M

P/E Ratio:

-6.0287

EPS:

-2.09

Net Cash Flow:

$-45.03M

1W Performance:

+36.96%

1M Performance:

+115.02%

6M Performance:

+2,607%

1Y Performance:

+850.94%

1-Day Range:

$11.46

$13.15

1-Week Range:

$8.51

$13.15

52-Week Range:

$0.224

$13.17

Nextcure Inc Stock (NXTC) Company Profile

Name

Nextcure Inc

Sector

Healthcare (1135)

Industry

Biotechnology (635)

Phone

240-399-4900

Address

9000 VIRGINIA MANOR ROAD, SUITE 200, BELTSVILLE, MD

Employee

Twitter

@nextcureinc

Next Earnings Date

2025-03-07

Latest SEC Filings

NXTC's Discussions on Twitter

Compare NXTC with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
NXTC Nextcure Inc	12.60	32.78M	0	-58.52M	-45.03M	-2.09
VRTX Vertex Pharmaceuticals Inc	425.57	107.66B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	651.80	68.74B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	456.04	58.93B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	818.50	50.51B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	189.60	41.29B	447.02M	-1.18B	-868.57M	-6.1812

Nextcure Inc Stock (NXTC) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-04-22	Downgrade	Ladenburg Thalmann	Buy → Neutral
Mar-01-22	Initiated	Ladenburg Thalmann	Buy
Mar-05-21	Upgrade	Truist	Hold → Buy
Jan-15-21	Downgrade	BofA Securities	Neutral → Underperform
Jul-16-20	Upgrade	The Benchmark Company	Hold → Buy
Jul-13-20	Downgrade	ROTH Capital	Buy → Neutral
Jul-13-20	Downgrade	SunTrust	Buy → Hold
Jun-01-20	Downgrade	BofA/Merrill	Buy → Neutral
Jun-01-20	Downgrade	The Benchmark Company	Buy → Hold
May-26-20	Initiated	JMP Securities	Mkt Outperform
Mar-24-20	Initiated	The Benchmark Company	Buy
Mar-02-20	Initiated	ROTH Capital	Buy
Jan-13-20	Initiated	SunTrust	Buy
Dec-05-19	Initiated	Needham	Buy
Nov-26-19	Initiated	BTIG Research	Buy
Jul-09-19	Initiated	BofA/Merrill	Buy
Jun-03-19	Initiated	Morgan Stanley	Overweight
Jun-03-19	Initiated	Piper Jaffray	Overweight

View All

Nextcure Inc Stock (NXTC) Latest News

03:15 AM

What technical models suggest about NextCure Inc.’s comebackStock Surge & AI Forecasted Entry/Exit Points - newser.com

03:15 AM

12:03 PM

How to integrate NextCure Inc. into portfolio analysis toolsMarket Movement Recap & Free Low Drawdown Momentum Trade Ideas - newser.com

12:03 PM

Nov 02, 2025

How NextCure Inc. stock reacts to inflationary pressures2025 Market Sentiment & Fast Moving Stock Trade Plans - newser.com

Nov 02, 2025

Is NextCure Inc. stock reversal real or fake2025 Buyback Activity & Risk Controlled Stock Alerts - newser.com

Nov 02, 2025

How sentiment analysis helps forecast NextCure Inc.July 2025 Retail & Fast Entry High Yield Tips - newser.com

Nov 02, 2025

Key metrics from NextCure Inc.’s quarterly data2025 Retail Activity & Low Drawdown Trading Techniques - newser.com

Nov 02, 2025

Comparing NextCure Inc. in custom built stock radarsTrade Risk Summary & Real-Time Chart Pattern Alerts - newser.com

Nov 02, 2025

Has NextCure Inc. found a price floorWatch List & Trade Opportunity Analysis Reports - newser.com

Nov 02, 2025

Nov 01, 2025

NextCure Inc Stock Analysis and ForecastSector Rotation Strategies & These 3 Stocks Could Change Your Portfolio - earlytimes.in

Nov 01, 2025

Oct 31, 2025

Evaluating NextCure Inc. with trendline analysisPortfolio Update Report & Expert Approved Momentum Trade Ideas - newser.com

Oct 31, 2025

How institutional ownership impacts NextCure Inc. stockJuly 2025 Catalysts & Daily Risk Controlled Trade Plans - newser.com

Oct 31, 2025

Why analysts remain bullish on NextCure Inc. stockWeekly Risk Summary & Weekly Market Pulse Alerts - newser.com

Oct 31, 2025

Best data tools to analyze NextCure Inc. stockMarket Movement Recap & Real-Time Buy Zone Alerts - newser.com

Oct 31, 2025

Using Python tools to backtest NextCure Inc. strategies2025 Top Gainers & Daily Profit Maximizing Tips - newser.com

Oct 31, 2025

Predicting NextCure Inc. trend using moving averagesJuly 2025 Reactions & Breakout Confirmation Trade Signals - newser.com

Oct 31, 2025

Visual analytics tools that track NextCure Inc. performance2025 Historical Comparison & Stepwise Swing Trade Plans - newser.com

Oct 31, 2025

What MACD signals say about NextCure Inc.Quarterly Portfolio Summary & Low Volatility Stock Recommendations - newser.com

Oct 31, 2025

Oct 30, 2025